skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Effect of acyclovir on radiation- and chemotherapy-induced mouth lesions

Journal Article · · Antimicrobial Agents and Chemotherapy; (USA)
DOI:https://doi.org/10.1128/AAC.33.6.862· OSTI ID:5543410
; ; ; ;  [1]
  1. Harvard-Thorndike Laboratory of Beth Israel Hospital, Boston, MA (USA)

Several chemotherapeutic regimens and radiation therapy, if delivered to the oral mucosa, are associated with a high frequency of mouth lesions. The cause of this side effect is not known for certain, but in past studies it has sometimes been associated with the ability to culture herpes simplex virus type 1 from the mouth. In a double-blind prospective trial, patients with head and neck tumors treated with chemotherapy or radiation therapy were treated with either acyclovir or placebo. Although the frequency of culture-positive herpes simplex virus was low in the untreated group, it was significantly lower, zero, in the acyclovir-treated group. However, there were no differences in the frequency or type of mouth lesions experienced by patients receiving either radiation or chemotherapy who were taking acyclovir or placebo. These results suggest that herpes simplex virus is not a frequent cause or complication of oral lesions afflicting this patient population.

OSTI ID:
5543410
Journal Information:
Antimicrobial Agents and Chemotherapy; (USA), Vol. 33:6; ISSN 0066-4804
Country of Publication:
United States
Language:
English

Similar Records

Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents
Journal Article · Wed Nov 01 00:00:00 EST 1995 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:5543410

Stages III and IV Squamous Cell Carcinoma of the Mouth: Three-Year Experience with Superselective Intraarterial Chemotherapy Using Cisplatin Prior to Definitive Treatment
Journal Article · Sat May 15 00:00:00 EDT 1999 · Cardiovascular and Interventional Radiology · OSTI ID:5543410

Gemcitabine-Based Combination Chemotherapy Followed by Radiation With Capecitabine as Adjuvant Therapy for Resected Pancreas Cancer
Journal Article · Tue Dec 01 00:00:00 EST 2009 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:5543410